| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-04-27 23:10:36 UTC |
|---|
| Updated at | 2022-04-27 23:10:36 UTC |
|---|
| NP-MRD ID | NP0051970 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Triobolide |
|---|
| Description | Trilobolide belongs to the class of organic compounds known as tetracarboxylic acids and derivatives. These are carboxylic acids containing exactly four carboxyl groups. Triobolide is found in Laser trilobum, Laserpitium siler and Thapsia transtagana. Triobolide was first documented in 2015 (PMID: 26474674). Based on a literature review a significant number of articles have been published on Trilobolide (PMID: 34355433) (PMID: 33797641) (PMID: 33291419) (PMID: 31501660) (PMID: 30731148) (PMID: 28781697). |
|---|
| Structure | CC[C@H](C)C(=O)O[C@H]1C[C@](C)(OC(C)=O)[C@H]2C[C@@H](OC(=O)C(\C)=C/C)C(C)=C2[C@@H]2OC(=O)[C@@](C)(O)[C@@]12O InChI=1S/C27H38O10/c1-9-13(3)22(29)34-18-11-17-20(15(18)5)21-27(33,26(8,32)24(31)36-21)19(35-23(30)14(4)10-2)12-25(17,7)37-16(6)28/h9,14,17-19,21,32-33H,10-12H2,1-8H3/b13-9-/t14-,17-,18+,19-,21-,25-,26+,27+/m0/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C27H38O10 |
|---|
| Average Mass | 522.5910 Da |
|---|
| Monoisotopic Mass | 522.24650 Da |
|---|
| IUPAC Name | (3S,3aR,4S,6S,6aS,8R,9bS)-6-(acetyloxy)-3,3a-dihydroxy-3,6,9-trimethyl-4-{[(2S)-2-methylbutanoyl]oxy}-2-oxo-2H,3H,3aH,4H,5H,6H,6aH,7H,8H,9bH-azuleno[4,5-b]furan-8-yl (2Z)-2-methylbut-2-enoate |
|---|
| Traditional Name | trilobolide |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC[C@H](C)C(=O)O[C@H]1C[C@](C)(OC(C)=O)[C@H]2C[C@@H](OC(=O)C(\C)=C/C)C(C)=C2[C@@H]2OC(=O)[C@@](C)(O)[C@@]12O |
|---|
| InChI Identifier | InChI=1S/C27H38O10/c1-9-13(3)22(29)34-18-11-17-20(15(18)5)21-27(33,26(8,32)24(31)36-21)19(35-23(30)14(4)10-2)12-25(17,7)37-16(6)28/h9,14,17-19,21,32-33H,10-12H2,1-8H3/b13-9-/t14-,17-,18+,19-,21-,25-,26+,27+/m0/s1 |
|---|
| InChI Key | FIAZIVNRHQWTPY-QAAPNFDWSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as tetracarboxylic acids and derivatives. These are carboxylic acids containing exactly four carboxyl groups. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Tetracarboxylic acids and derivatives |
|---|
| Direct Parent | Tetracarboxylic acids and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Tetracarboxylic acid or derivatives
- Fatty acid ester
- Gamma butyrolactone
- Fatty acyl
- Cyclic alcohol
- Tertiary alcohol
- Tetrahydrofuran
- Enoate ester
- Alpha,beta-unsaturated carboxylic ester
- Lactone
- 1,2-diol
- Carboxylic acid ester
- Organoheterocyclic compound
- Oxacycle
- Hydrocarbon derivative
- Alcohol
- Organooxygen compound
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Aliphatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aliphatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Zhou XQ, Mao XM, Fan R, Li SY, Shang J, Zhang T, Li RH, Li HQ, Hui Y, Chen WH, Wang ZX, Shen DY: Trilobolide-6-O-isobutyrate suppresses hepatocellular carcinoma tumorigenesis through inhibition of IL-6/STAT3 signaling pathway. Phytother Res. 2021 Oct;35(10):5741-5753. doi: 10.1002/ptr.7233. Epub 2021 Aug 6. [PubMed:34355433 ]
- Christensen SB, Simonsen HT, Engedal N, Nissen P, Moller JV, Denmeade SR, Isaacs JT: From Plant to Patient: Thapsigargin, a Tool for Understanding Natural Product Chemistry, Total Syntheses, Biosynthesis, Taxonomy, ATPases, Cell Death, and Drug Development. Prog Chem Org Nat Prod. 2021;115:59-114. doi: 10.1007/978-3-030-64853-4_2. [PubMed:33797641 ]
- Zimmermann T, Drasar P, Rimpelova S, Christensen SB, Khripach VA, Jurasek M: Large Scale Conversion of Trilobolide into the Payload of Mipsagargin: 8-O-(12-Aminododecanoyl)-8-O-Debutanoylthapsigargin. Biomolecules. 2020 Dec 5;10(12). pii: biom10121640. doi: 10.3390/biom10121640. [PubMed:33291419 ]
- Rimpelova S, Jurasek M, Peterkova L, Bejcek J, Spiwok V, Majdl M, Jirasko M, Budesinsky M, Harmatha J, Kmonickova E, Drasar P, Ruml T: Archangelolide: A sesquiterpene lactone with immunobiological potential from Laserpitium archangelica. Beilstein J Org Chem. 2019 Aug 13;15:1933-1944. doi: 10.3762/bjoc.15.189. eCollection 2019. [PubMed:31501660 ]
- Harmatha J, Budesinsky M, Jurasek M, Zimmermann T, Drasar P, Zidek Z, Kmonickova E, Vejvodova L: Structural modification of trilobolide for upgrading its immunobiological properties and reducing its cytotoxic action. Fitoterapia. 2019 Apr;134:88-95. doi: 10.1016/j.fitote.2019.02.002. Epub 2019 Feb 4. [PubMed:30731148 ]
- Skorpilova L, Rimpelova S, Jurasek M, Budesinsky M, Lokajova J, Effenberg R, Slepicka P, Ruml T, Kmonickova E, Drasar PB, Wimmer Z: BODIPY-based fluorescent liposomes with sesquiterpene lactone trilobolide. Beilstein J Org Chem. 2017 Jul 4;13:1316-1324. doi: 10.3762/bjoc.13.128. eCollection 2017. [PubMed:28781697 ]
- Huml L, Jurasek M, Miksatkova P, Zimmermann T, Tomanova P, Budesinsky M, Rottnerova Z, Simkova M, Harmatha J, Kmonickova E, Lapcik O, Drasar PB: Immunoassay for determination of trilobolide. Steroids. 2017 Jan;117:105-111. doi: 10.1016/j.steroids.2016.08.019. Epub 2016 Sep 4. [PubMed:27600788 ]
- Jurasek M, Dzubak P, Rimpelova S, Sedlak D, Konecny P, Frydrych I, Gurska S, Hajduch M, Bogdanova K, Kolar M, Muller T, Kmonickova E, Ruml T, Harmatha J, Drasar PB: Trilobolide-steroid hybrids: Synthesis, cytotoxic and antimycobacterial activity. Steroids. 2017 Jan;117:97-104. doi: 10.1016/j.steroids.2016.08.011. Epub 2016 Aug 17. [PubMed:27543674 ]
- Harmatha J, Vokac K, Budesinsky M, Zidek Z, Kmonickova E: Immunobiological properties of sesquiterpene lactones obtained by chemically transformed structural modifications of trilobolide. Fitoterapia. 2015 Dec;107:90-99. doi: 10.1016/j.fitote.2015.10.002. Epub 2015 Oct 22. [PubMed:26474674 ]
- Tomanova P, Rimpelova S, Jurasek M, Budesinsky M, Vejvodova L, Ruml T, Kmonickova E, Drasar PB: Trilobolide-porphyrin conjugates: on synthesis and biological effects evaluation. Steroids. 2015 May;97:8-12. doi: 10.1016/j.steroids.2014.08.024. Epub 2014 Sep 6. [PubMed:25204594 ]
|
|---|